4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049666
SVP & Chief Financial Officer sold 3,177 shares at $19.32 ($61,380)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2017-08-16 | Sale | −3,177 | $19.32 | $61,380 | 63,414 | D: show line 1 in the form |
| Open-market sales · 3,177 sh · avg $19.32 · $61,380 | |||||||
Loading xslF345X03/doc4.xml…